ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2026
A Retrospective Study Examining Predictors of Treatment Response in Over 1,300 Children and Adolescents with Attention-deficit Hyperactivity Disorder.
Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to examine the predictors of treatment response in children and adolescents with attention-deficit hyperactivity disorder (ADHD). Methods: The study included 1,314 patients with ADHD who came to the child psychiatry department over a 5-year period. The 276 patients whose treatment was changed due to treatment non-response or side effects were included twice for the first and second treatment, so a total of 1,590 patient data were used. Age, sex, initial ADHD severity, ADHD treatment, treatment response, comorbidities, additional treatments, and chronic disease status of the cases were recorded. Results: One thousand twenty-seven (78.16%) of the patients were male and 287 (21.84%) were female. Using the combination therapy of methylphenidate (MPH) and atomoxetine (ATX) as the reference category, ATX monotherapy showed a significantly lower likelihood of responding to treatment. Moderate and marked disorder severity were associated with higher odds compared with severe disorder. Borderline intellectual functioning (BIF), mild intellectual disability, conduct disorder (CD), autism spectrum disorder (ASD), and adjustment disorder (AD) showed significantly lower odds. Older age was significantly associated with response to treatment. In the MPH monotherapy and ATX monotherapy groups, compared to moderate disorder, severe disorder was associated with significantly lower odds. BIF, CD, ASD, enuresis, communication disorders, and AD showed significantly lower odds in MPH group, while only ASD had significantly lower odds in ATX group. Higher ATX dosage was significantly associated with treatment response in this group. Conclusion: Knowing the factors affecting treatment response can be used to predict prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.